TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 1 | -99.9% | 0.00% | -100.0% |
Q1 2016 | $56,000 | -21.1% | 1,515 | +1.6% | 0.00% | -50.0% |
Q2 2015 | $71,000 | +26.8% | 1,491 | -1.6% | 0.00% | +100.0% |
Q1 2015 | $56,000 | -23.3% | 1,515 | -17.7% | 0.00% | -50.0% |
Q4 2014 | $73,000 | – | 1,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |